Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway.

Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway.
复制标题

DOI:
10.1186/s13046-017-0495-3
复制
发表时间:
2017-02-07
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
通讯作者:
Chen JJ
Chen JJ
中科院分区:
其他
文献类型:
--
作者:
Cheng HW;Chen YF;Wong JM;Weng CW;Chen HY;Yu SL;Chen HW;Yuan A;Chen JJ

文献摘要

被引文献

相似文献

血管生成是癌症的标志,在肺癌进展中起着关键作用,涉及癌细胞、内皮细胞和周围微环境之间的相互作用。然而,血管内皮细胞与肺癌细胞相互作用后的基因表达谱和生物学表型的变化仍不清楚。采用间接transwell共培养系统,观察人脐静脉内皮细胞(HUVECs)与人肺腺癌细胞系CL 1 -5相互作用后,HUVECs的形态学和分子生物学变化。采用基因芯片技术筛选HUVECs与癌细胞共培养后的差异表达基因。此外,一个公开的微阵列数据集的293个非小细胞肺癌(NSCLC)患者被用来评估的预后能力的基因签名来源于HUVEC。HUVEC与肺癌细胞之间的相互作用改变了HUVEC的形态,使其具有间充质样形态并改变其细胞骨架组织。此外,与肺癌细胞共培养后,HUVECs表现出细胞运动性和微血管管形成能力增加,凋亡百分比降低。HUVECs的转录组学分析显示,许多生存,凋亡和血管生成相关基因的差异表达后与肺癌细胞的相互作用。进一步研究表明,PI 3 K/Akt信号通路和考克斯-2参与了肺癌细胞刺激下内皮管的形成。此外,Rac-1激活可能通过增加板状伪足和丝状伪足的形成来促进内皮细胞运动。PI 3 K和考克斯-2抑制剂可以逆转管状形成增加并诱导HUVEC凋亡。此外,来自HUVEC中DEG的基因签名可以预测NSCLC患者的总生存期和无病生存期,并作为独立的预后因素。在这项研究中,我们发现癌细胞可以促进内皮细胞管的形成和存活,至少部分是通过PI 3 K/Akt信号通路,从而改变微环境,有利于肿瘤生长。来自HUVEC的基因特征与NSCLC患者的临床结果相关。本文的在线版本(doi:10.1186/s13046-017-0495-3)包含补充材料,可供授权用户使用。
Angiogenesis is a hallmark of cancer and plays a critical role in lung cancer progression, which involves interactions between cancer cells, endothelial cells and the surrounding microenvironment. However, the gene expression profiles and the changes in the biological phenotype of vascular endothelial cells after interactions with lung cancer cells remain unclear. An indirect transwell co-culture system was used to survey the interaction between human umbilical vein endothelial cells (HUVECs) and human lung adenocarcinoma CL1-5 cells, as well as to investigate the morphological and molecular changes of HUVECs. The differentially expressed genes (DEGs) in HUVECs after co-culture with cancer cells were identified by microarray. Moreover, a publicly available microarray dataset of 293 non-small-cell lung cancer (NSCLC) patients was employed to evaluate the prognostic power of the gene signatures derived from HUVECs. The interaction between HUVECs and lung cancer cells changes the morphology of HUVECs, causing them to have a mesenchymal-like morphology and alter their cytoskeleton organization. Furthermore, after co-culture with lung cancer cells, HUVECs showed increased cell motility and microvessel tube formation ability and a decreased apoptotic percentage. Transcriptomic profiling of HUVECs revealed that many survival-, apoptosis- and angiogenesis-related genes were differentially expressed after interactions with lung cancer cells. Further investigations showed that the PI3K/Akt signalling pathway and COX-2 are involved in endothelial tube formation under the stimulation of lung cancer cells. Moreover, Rac-1 activation might promote endothelial cell motility through the increased formation of lamellipodia and filopodia. The inhibitors of PI3K and COX-2 could reverse the increased tube formation and induce the apoptosis of HUVECs. In addition, the gene signatures derived from the DEGs in HUVECs could predict overall survival and disease-free survival in NSCLC patients and serve as an independent prognostic factor. In this study, we found that cancer cells can promote endothelial cell tube formation and survival, at least in part, through the PI3K/Akt signalling pathway and thus change the microenvironment to benefit tumour growth. The gene signatures from HUVECs are associated with the clinical outcome of NSCLC patients. The online version of this article (doi:10.1186/s13046-017-0495-3) contains supplementary material, which is available to authorized users.